Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH28189FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International Inc (CRL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions for cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory and musculoskeletal therapeutic areas. Charles River caters products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

Nov 12,2020: Charles River and PathoQuest strengthen strategic partnership
Oct 29,2020: Charles River Laboratories announces third-quarter 2020 results
Oct 16,2020: Charles River Laboratories adds George Llado to board of directors
Aug 05,2020: Charles River Laboratories announces second-quarter 2020 results
Aug 05,2020: Charles River to acquire Cellero

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Charles River Laboratories International Inc – Key Facts
Charles River Laboratories International Inc – Key Employees
Charles River Laboratories International Inc – Key Employee Biographies
Charles River Laboratories International Inc – Major Products and Services
Charles River Laboratories International Inc – History
Charles River Laboratories International Inc – Company Statement
Charles River Laboratories International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Charles River Laboratories International Inc – Business Description
Business Segment: Discovery and Safety Assessment
Overview
Performance
Business Segment: Manufacturing Support
Overview
Performance
Business Segment: Research Models and Services
Overview
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: US
Performance
Charles River Laboratories International Inc – Corporate Strategy
Charles River Laboratories International Inc – SWOT Analysis
SWOT Analysis – Overview
Charles River Laboratories International Inc – Strengths
Charles River Laboratories International Inc – Weaknesses
Charles River Laboratories International Inc – Opportunities
Charles River Laboratories International Inc – Threats
Charles River Laboratories International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Charles River Laboratories International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2020: Charles River and PathoQuest strengthen strategic partnership
Oct 29, 2020: Charles River Laboratories announces third-quarter 2020 results
Oct 16, 2020: Charles River Laboratories adds George Llado to board of directors
Aug 05, 2020: Charles River Laboratories announces second-quarter 2020 results
Jun 02, 2020: HemaCare adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio
May 07, 2020: Charles River Laboratories announces first-quarter 2020 results
Mar 30, 2020: Charles River Laboratories and Deciphex form a partnership to enhance drug discovery & development with digital pathology
Mar 04, 2020: Charles River Laboratories adds Nancy C. Andrews, M.D., Ph.D., to board of directors
Feb 11, 2020: Charles River Laboratories announces fourth-quarter and full-year 2019 results and provides 2020 guidance
Jan 23, 2020: Strategic Partnership seen as a game changer for Edinburgh-based Fios Genomics
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Charles River Laboratories International Inc, Key Facts
Charles River Laboratories International Inc, Key Employees
Charles River Laboratories International Inc, Key Employee Biographies
Charles River Laboratories International Inc, Major Products and Services
Charles River Laboratories International Inc, History
Charles River Laboratories International Inc, Subsidiaries
Charles River Laboratories International Inc, Key Competitors
Charles River Laboratories International Inc, Ratios based on current share price
Charles River Laboratories International Inc, Annual Ratios
Charles River Laboratories International Inc, Annual Ratios (Cont...1)
Charles River Laboratories International Inc, Annual Ratios (Cont...2)
Charles River Laboratories International Inc, Interim Ratios
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Charles River Laboratories International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • New York Power Authority:戦略・SWOT・企業財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Naspers Limited:企業の戦略・SWOT・財務情報
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EnCana Corp (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NovImmune SA-製薬・医療分野:企業M&A・提携分析
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • Sunkist Growers Inc:企業の戦略的SWOT分析
    Sunkist Growers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natu …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • China Petroleum & Chemical Corp (600028):石油・ガス:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Dalian Wanda Group:企業の戦略・SWOT・財務情報
    Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report Summary Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Waagner-Biro Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Waagner-Biro Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • UK Green Investment Bank Ltd:電力:M&Aディール及び事業提携情報
    Summary UK Green Investment Bank Ltd (UK Green) is an investment firm that offers green infrastructure investment services in the UK. The firm primarily invests on renewable energy and energy efficiency projects that include offshore wind, green deals and waste and bio energy and onshore renewable e …
  • Compugen Ltd (CGEN):企業の財務・戦略的SWOT分析
    Summary Compugen Ltd (Compugen) is a predictive drug discovery and development company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises COM701 and PVRIG, BAY 1905254, COM902 and TIGIT; and CGEN-XXXX/Myeloid and autoimmune diseases …
  • Sykes Enterprises Inc (SYKE)
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆